Century Therapeutics, Inc. (IPSC) — Dilution Risk Analysis

Current Snapshot

Century Therapeutics, Inc. (IPSC) has a DilutionWatch score of 60/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Dilution Risk Score

Score: 60/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

1 shelf registration or ATM offering filing detected in recent history.

Recent filing forms in the source payload: 4 8, 424B5 1, 8-K 1.

Form	Filed	Accession
4	2026-04-03	0002039294-26-000008
424B5	2026-03-26	0001104659-26-035255
8-K	2026-03-26	0001104659-26-035256
4	2026-03-16	0001867305-26-000006
4	2026-03-16	0001867173-26-000008
4	2026-03-13	0002039294-26-000006
4	2026-03-13	0002001162-26-000006
4	2026-03-11	0001867173-26-000006
4	2026-03-11	0001867305-26-000004
4	2026-03-10	0002001162-26-000004

Dilution Risk Drivers

Driver	Stored Value	Source
Shelf registration capacity	$135,000,000	Source
ATM offering capacity remaining	$131,619,741	Source
Cash runway	12 months	Source
Three-year share count growth	202.62%	Source

DilutionWatch Analysis

Risk Level: HIGH (Score: 60/10) Source
Cash Runway: 12 months Source
ATM Offering Capacity Remaining: $131,619,741 Source
Shelf Registration Capacity: $135,000,000 Source
Share Count Growth (3-Year): 202.62% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.